D. E. Shaw & Co., Inc. Praxis Precision Medicines, Inc. Transaction History

D. E. Shaw & Co., Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$1.88 - $36.45 $545,889 - $10.6 Million	290,367 Added 102.22%	574,426 $1.37 Million
Q3 2022 Nov 14, 2022	BUY	$2.5 - $37.95 $467,840 - $7.1 Million	187,136 Added 193.08%	284,059 $645,000
Q2 2022 Aug 15, 2022	BUY	$1.75 - $11.34 $169,615 - $1.1 Million	96,923 New	96,923 $237,000
Q3 2021 Nov 15, 2021	SELL	$13.15 - $22.56 $595,221 - $1.02 Million	-45,264 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.28 - $33.05 $827,425 - $1.5 Million	45,264 New	45,264 $827,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.